3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
128
Colonic Neoplasms
54
Rectal Neoplasms
49
Carcinoma, Hepatocellular
29
Stomach Neoplasms
23
Neoplasm Metastasis
20
Pancreatic Neoplasms
10
Cholangiocarcinoma
9
Neoplasms
8
Adenocarcinoma Of Esophagus
8
Esophageal Neoplasms
7
Liver Neoplasms
6
Gastrointestinal Neoplasms
5
Biliary Tract Neoplasms
5
Recurrence
4
Ovarian Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Digestive System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Unresectable Metastatic Colorectal Cancer
2
Neurotoxicity Syndromes
2
Neoplastic Cells, Circulating
2
Intestinal Neoplasms
2
Gastrointestinal Diseases
2
Gallbladder Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Breast Neoplasms
2
Adenocarcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Gemcitabine
61
Cisplatin
39
Oxaliplatin
31
Capecitabine
29
Fluorouracil
22
Leucovorin
20
Irinotecan
12
pembrolizumab
11
130-nm albumin-bound paclitaxel
10
durvalumab
9
Erlotinib Hydrochloride
8
Trastuzumab
7
Bevacizumab
7
Taxes
6
Platinum
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Albumin-Bound Paclitaxel
6
1,2-diaminocyclohexaneplatinum II citrate
6
Specimen Handling
5
Sorafenib
5
Radiotherapy
5
Docetaxel
5
Carboplatin
5
Immunohistochemistry
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
atezolizumab
3
Watchful Waiting
3
Tegafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Folfox protocol
×
Gastrointestinal
×
Clear all
NCT05712356
2026-05-26
BOLSTER
Lisata Therapeutics, Inc.
Phase 2
Terminated
66 enrolled
12 charts
NCT07265674
2026-05-14
Beacon-BTC
J-Pharma Co., Ltd.
Phase 3
Recruiting
480 enrolled